Endeavour Vision

Endeavour Vision, based in Geneva, Switzerland, is a prominent growth-stage venture capital firm dedicated to investing in the medtech and digital health sectors. With a strategic focus on companies in Europe and the US, the firm targets innovative businesses that have moved beyond the early development phase, demonstrating proven products and initial market traction. Their investment thesis centers on supporting companies poised for significant commercial scale-up and international expansion, leveraging their deep industry expertise and extensive network.

The firm's investment strategy is characterized by a commitment to partnering with management teams to accelerate growth. Endeavour Vision typically engages in Series B, C, and D funding rounds, providing not just capital but also strategic guidance on market access, regulatory navigation, and operational excellence. They seek companies with robust clinical evidence, clear value propositions, and strong intellectual property, aiming to foster the development of solutions that address significant unmet medical needs or improve healthcare efficiency.

Endeavour Vision manages substantial capital, with over $500 million in assets under management across its various funds. Their most recent fund, Fund IV, successfully closed at $315 million in 2021, significantly exceeding its initial target. This capital enables them to make substantial commitments, with typical first cheque sizes ranging from $10 million to $30 million per company. Their portfolio currently comprises over 20 companies, reflecting a diversified yet focused approach within their specialized domains, including notable investments in areas like surgical robotics, cardiovascular devices, and remote patient monitoring platforms.

The firm's long-term vision is to back disruptive technologies that can reshape the healthcare landscape. By focusing on growth-stage companies, Endeavour Vision aims to bridge the gap between early-stage innovation and large-scale commercialization, providing the critical capital and strategic support needed for companies to achieve market leadership and ultimately deliver significant returns for their investors. Their disciplined approach and specialized focus have established them as a key player in the global health technology investment ecosystem.